Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 1.
Figure 1.

Illustration of empirical allelic ratios between tumor and normal genomic sequencing data from chromosome 20 of a triple-negative breast cancer genome (SA225), and effects of copy number. (A) Allelic ratio data of heterozygous loci in the normal genome are centered around 0.5, which represents the presence of two alleles. (B) At the same corresponding loci, allelic ratios in the tumor genome reveal four examples of somatically acquired segments of allelic imbalance in regions (i)–(iv). (C) The segmental copy number of the tumor helps give context to the allelic data: (i) copy neutral LOH (NLOH), AA/BB; (ii) deletion-induced LOH (DLOH), A/B; (iii) amplified LOH (ALOH), AAA/BBB; and (iv) allele-specific amplification (ASCNA), AAAB/ABBB. Allelic ratio value is defined as the reference read counts divided by total depth at a given position. A and B represent reference and nonreference alleles in the genotype, respectively.

This Article

  1. Genome Res. 22: 1995-2007

Preprint Server